Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks.
adverse outcome pathway
certainty assessment
evidence-based toxicology
new approach methodologies
systematic evidence synthesis
Journal
ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
02
2022
accepted:
28
02
2022
entrez:
8
3
2022
pubmed:
9
3
2022
medline:
27
7
2022
Statut:
ppublish
Résumé
The workshop titled “Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks” was co-organized by the Evidence-based Toxicology Collaboration and the European Food Safety Authority (EFSA) and hosted by EFSA at its headquarters in Parma, Italy on October 2 and 3, 2019. The goal was to explore integration of systematic review with mechanistic evidence evaluation. Participants were invited to work on concrete products to advance the exploration of how evidence-based approaches can support the development and application of adverse outcome pathways (AOP) in chemical risk assessment. The workshop discussions were centered around three related themes: 1) assessing certainty in AOPs, 2) literature-based AOP development, and 3) integrating certainty in AOPs and non-animal evidence into decision frameworks. Several challenges, mostly related to methodology, were identified and largely determined the workshop recommendations. The workshop recommendations included the comparison and potential alignment of processes used to develop AOP and systematic review methodology, including the translation of vocabulary of evidence-based methods to AOP and vice versa, the development and improvement of evidence mapping and text mining methods and tools, as well as a call for a fundamental change in chemical risk and uncertainty assessment methodology if to be conducted based on AOPs and new approach methodologies (NAM). The usefulness of evidence-based approaches for mechanism-based chemical risk assessments was stressed, particularly the potential contribution of the rigor and transparency inherent to such approaches in building stakeholders’ trust for implementation of NAM evidence and AOPs into chemical risk assessment.
Identifiants
pubmed: 35258090
doi: 10.14573/altex.2202141
pmc: PMC9466297
mid: NIHMS1831306
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
499–518Subventions
Organisme : Intramural EPA
ID : EPA999999
Pays : United States
Références
Arch Toxicol. 2021 Jun;95(6):1867-1897
pubmed: 33851225
Toxicol Sci. 2013 Nov;136(1):97-106
pubmed: 23945500
Environ Health Perspect. 2019 Jul;127(7):75001
pubmed: 31322437
Environ Health Perspect. 2014 Oct;122(10):1040-51
pubmed: 24968389
Toxicol Appl Pharmacol. 2019 Oct 15;381:114711
pubmed: 31425687
Environ Health Perspect. 2010 Apr;118(4):485-92
pubmed: 20368123
Environ Health Perspect. 2019 Jun;127(6):65001
pubmed: 31199676
Nature. 2009 Sep 10;461(7261):158
pubmed: 19741676
J Conserv Dent. 2014 Jul;17(4):301-4
pubmed: 25125839
PLoS One. 2016 Sep 21;11(9):e0161851
pubmed: 27653281
Syst Rev. 2019 Jul 11;8(1):163
pubmed: 31296265
BMJ. 2016 Jun 28;353:i2016
pubmed: 27353417
Environ Int. 2016 Jul-Aug;92-93:716-28
pubmed: 27156197
Environ Int. 2019 Sep;130:104871
pubmed: 31254867
Front Artif Intell. 2021 Aug 05;4:685298
pubmed: 34423285
Curr Opin Toxicol. 2018 Jun 01;9:1-7
pubmed: 29682628
Environ Toxicol Chem. 2019 Sep;38(9):1850-1865
pubmed: 31127958
EFSA J. 2017 Mar 16;15(3):e04691
pubmed: 32625422
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
J Epidemiol Community Health. 2011 May;65(5):392-5
pubmed: 20947872
Regul Toxicol Pharmacol. 2014 Dec;70(3):629-40
pubmed: 25261300
Basic Clin Pharmacol Toxicol. 2018 Sep;123 Suppl 5:51-55
pubmed: 29604238
J Clin Epidemiol. 2018 Dec;104:103-112
pubmed: 30253221
Environ Pollut. 2011 Oct;159(10):2487-92
pubmed: 21763042
Environ Toxicol Chem. 2010 Mar;29(3):730-41
pubmed: 20821501
ALTEX. 2021 Apr 08;38(2):336-347
pubmed: 33837437
Crit Rev Toxicol. 2013 Oct;43(9):753-84
pubmed: 24040995
Environ Int. 2021 Nov;156:106760
pubmed: 34256299
Int J Technol Assess Health Care. 2017 Jan;33(2):176-182
pubmed: 28655365
J Clin Epidemiol. 2022 Jun;146:32-46
pubmed: 35219805
Environ Sci Technol. 2020 Jul 21;54(14):8491-8499
pubmed: 32584560
Environ Health Perspect. 2017 Aug 03;125(8):086001
pubmed: 28799918
Appl In Vitro Toxicol. 2017 Dec 01;3(4):298-311
pubmed: 30057931
Environ Health Perspect. 2014 Jul;122(7):711-8
pubmed: 24755067
Nat Rev Endocrinol. 2020 Jan;16(1):45-57
pubmed: 31719706
Environ Int. 2016 Jul-Aug;92-93:630-46
pubmed: 27039952
Environ Int. 2016 Jul-Aug;92-93:611-6
pubmed: 26827182
Syst Rev. 2020 May 4;9(1):100
pubmed: 32366302
J Appl Toxicol. 2018 Dec;38(12):1460-1470
pubmed: 29806706
Environ Health Perspect. 2016 Jun;124(6):713-21
pubmed: 26600562
Toxicol Sci. 2014 Dec;142(2):312-20
pubmed: 25466378
Toxicol Lett. 2009 Sep 10;189(2):138-44
pubmed: 19477248
ALTEX. 2021 Mar 05;38(2):351-357
pubmed: 33677612
Neurotoxicology. 2017 Mar;59:240-255
pubmed: 27212452
Environ Health Perspect. 2014 Oct;122(10):1007-14
pubmed: 24968373
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Toxicology. 2021 Jul;459:152856
pubmed: 34252478
Arch Toxicol. 2017 Jul;91(7):2551-2575
pubmed: 28501917
Neurotoxicology. 2012 Aug;33(4):842-52
pubmed: 22138353
Arch Toxicol. 2017 Nov;91(11):3477-3505
pubmed: 29051992
ALTEX. 2013;30(2):119-30
pubmed: 23665802
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
Arch Toxicol. 2017 Apr;91(4):1523-1543
pubmed: 27542122
Risk Anal. 2009 Apr;29(4):485-7; discussion 492-7
pubmed: 19076321
Health Res Policy Syst. 2018 May 29;16(1):45
pubmed: 29843743
Crit Rev Toxicol. 2016 Feb;46(2):138-52
pubmed: 26451809
ALTEX. 2008;25(3):213-31
pubmed: 18841317
Regul Toxicol Pharmacol. 2015 Aug;72(3):514-37
pubmed: 25863193
Environ Int. 2020 Aug;141:105736
pubmed: 32434117
Res Synth Methods. 2011 Mar;2(1):33-42
pubmed: 26061598
Regul Toxicol Pharmacol. 1997 Feb;25(1):1-5
pubmed: 9056496
Environ Health Perspect. 2018 Jul 17;126(7):076001
pubmed: 30024384
Toxicology. 2018 Feb 15;395:1-8
pubmed: 29275117
PLoS Comput Biol. 2011 Dec;7(12):e1002310
pubmed: 22194678
J Matern Fetal Neonatal Med. 2015;28(18):2176-81
pubmed: 25382561
Nanomaterials (Basel). 2020 Jun 24;10(6):
pubmed: 32599945
J Appl Toxicol. 2014 Jun;34(6):595-606
pubmed: 24777878
Regul Toxicol Pharmacol. 2020 Oct;116:104721
pubmed: 32645429
Pharmacol Ther. 2017 Nov;179:84-95
pubmed: 28529068
Int J Mol Sci. 2021 May 10;22(9):
pubmed: 34068678
Res Synth Methods. 2018 Mar;9(1):13-24
pubmed: 28677339
J Clin Epidemiol. 2011 Apr;64(4):407-15
pubmed: 21247734